baber/WOPTO huggingface dataset:
Patent EP-0341319-A4 (EP)
Title: Digital tape recorder
IPC: G11B15/087
Filed: 1988-11-24
Abstract: When the content of start ID changes from 0 to 1, the start ID recorded in a subcode area on a tape indicates a starting point of the program. The invention is provided with storage means (55, 66, 75) that stores the tape position for starting the re-recording of start ID=1, and start ID discrimination means (54, 65, 74) for discriminating whether the start ID=1 is recorded or not just before the tape position at which the re-recording of start ID=1 is started. When it is discriminated by the start ID discrimination means that the start ID=1 is recorded, the tape is rewound up to the position where the start ID=0 is recorded, and the start ID=0 is recorded through up to the tape position stored in the storage means. Thereafter, the start ID=1 is recorded for a predetermined period of time. When it is discriminated that the start ID=0 is recorded, the start ID=1 is immediately recorded for a predetermined period of time from the tape position stored in the storage means to obviate cumbersome operation.
Patent EP-0469063-A4 (EP)
Title: Apparatus for igniting contained combustible materials
IPC: A01M1/20
Filed: 1990-04-16
Abstract: A reusable apparatus for igniting a combustible material within a vented container (12). Preferably, the actuator portion (11) includes a mechanism (26) for removably interconnecting the actuator with the container. An energy source (30) in the ignitor (11) ignites a combustible material (19) placed in an area adjacent to the interconnection between the actuator (11) and the container (12).
Patent EP-0436735-A4 (EP)
IPC: G01B11/24
Filed: 1990-07-12
Abstract: L'invention se rapporte à une unité de commande de profils sans contact, qui permet de profiler une pièce à travailler en suivant la forme d'un modèle sans aucun contact avec lui. Deux détecteurs de distance sans contact (5a, 5b) sont disposés obliquement sur une tête de traceur (4), laquelle est commandée par un arbre rotatif. Les valeurs mesurées par les détecteurs (5a, 5b) sont chacune échantillonnée à chaque moment d'échantillonnage prédéterminé. Les valeurs des coordonnées de chaque sommet d'un rectangle très petit situé sur le plan du modèle (6) sont obtenues à partir des valeurs mesurées antérieures et courantes et un vecteur normal est déterminé grâce à l'utilisation des valeurs des coordonnées de trois sommets spécifiés. La tête de traceur (4) est amenée à tourner dans la direction de projection de ce vecteur normal sur un plan X - Y. Ainsi, dès lors que la direction de chacun des axes de mesure des détecteurs (5a, 5b) s'approche autant que possible d'une direction perpendiculaire au plan du modèle, des mesures de distances très précises peuvent effectuées.
Patent EP-0507851-A4 (EP)
Title: Quinolone carboxylic acid--metal ion--acid complexes
IPC: A61K31/495
Filed: 1990-12-20
Abstract: Compositions of a quinolone carboxylic acids useful for oral or parenteral administration to a human or veterinary patient are disclosed which comprise quinolone carboxylic acid-metal ion-acid complexes in combination with a physiologically acceptable carrier and having a pH of about 4 to about 10, as well as a method for their production and use in treatment. Such compositions are found to cause unexpectedly low levels of vein irritation upon intravenous administration.
Patent EP-0503079-A4 (EP)
IPC: C07D401/12
Filed: 1991-09-30
Abstract: Dérivé d'éthynylphényle à substitution pyridazinone racémique ou énantiomère représenté par la formule générale (I), sel de ce dérivé acceptable en pharmacologie, et médicament contre les affections des organes circulatoires, les thromboses et les maladies rénales. Dans la formule, R1 représente hydrogène, alkyle C¿1?-C6, alcoxycarbonyle C1-C4, alkyle C1-C6 amino substitué, alkyle C1-C4 hydroxy, ou phényle substitué avec alkyle, alcoxy, nitro ou halogène; R?2¿ représente hydrogène, alcoxy C¿1?-C4 ou halogène; R?3¿ représente alcoxy C¿1?-C4, alkylamino C1-C6 ou alcoxy C1-C4 alcoxy C1-C4; R?4¿ représente alkyle C¿1?-C4 ou amino; R?5¿ représente hydrogène ou alkyle C¿1?-C4; R?6¿ représente hydrogène ou alkyle C¿1?-C4; et R?7¿ représente hydrogène ou alkyle C¿1?-C4.
Patent EP-0575329-A4 (EP)
IPC: C02F1/52
Filed: 1991-12-11
Abstract: The present invention describes a filter medium and a method of filtering metals from liquids, such as waste water, in which the metals are filtered from the liquids and are chemically fixed in the resulting filter cake in a nonhazardous and nontoxic form so that they may be disposed of in nonhazardous landfills. When all or a portion of the metals are dissolved, they are first precipitated and then filtered and chemically fixed.
Patent EP-0574423-A4 (EP)
Title: Selective call receiver having user defined message information in memory and presentation methods thereof.
Inventor: BODET PAUL WALTER
IPC: G08B5/22
Filed: 1991-12-12
Abstract: A user of a selective call receiver (100) is capable of inputting and storing user defined search key information and user defined corresponding information into non-volatile memory (107), via user input control (109). Subsequent to receiving and decoding a message having message information and storing the message information into memory (106), the selective call receiver (100) is capable of searching the message information for an occurrence of the user defined search key information, and presenting the message information and at least a portion of corresponding information for an occurrence of corresponding user defined search key information in the message information.
Patent EP-0632703-A4 (EP)
Title: Eating utensil.
Inventor: MACARTHUR-ONSLOW ROHAN JAMES
IPC: A47G21/04
Filed: 1993-03-16
Abstract: A foldable eating utensil includes an elongate handle member having a food-engaging blade extending integrally from one end thereof when operatively disposed, the blade being hingedly connected about a transverse axis to the inner edge of a connector plate of the handle member extending laterally between spaced handle arms of the handle member which define therebetween an opening to receive the blade to lie coplanar with the handle member when the blade is hinged to storage disposition, the blade including a longitudinally extending neck portion at its hinged connection to the connector plate and adapted to lie against the connector plate when operatively disposed, the handle arms being foldable each about a lengthwise axis adjacent the connector plate, and the parts being so made and arranged that when the blade has been hinged to operative disposition, the handle arms may be folded digitally towards each other and brought to and held in co-acting relationship in which parts of the handle member engage the blade at its neck portion in such manner as to restrain the blade against movement away from operative disposition.
Patent EP-0641289-A4 (EP)
Title: Liquid dispenser.
Inventor: LEVINE MARSHALL S
IPC: A61B19/00
Filed: 1993-03-12
Abstract: A dispenser for blood and other biological specimens is disclosed which provides a means of obtaining a small predetermined quantity of specimen from a closed container without the need to remove the stopper from the container. The cannula of the device is caused to pierce the container's rubber stopper forming an assembly. When the said assembly is forced against a target surface, such as microscope slide, the force compresses the stopper and thereby reduces the volume inside the container sufficiently to eject a drop of fluid which is dispensed onto a target surface. Stabilizing supports are provided so that fluid emerges from a dispensing tip located a predetermined distance above the target surface which determines the quantity of fluid dispensed. The supports also transmit reactive force from the target surface to compress the rubber stopper of the closed specimen tube.
Patent EP-0615851-A4 (EP)
Title: Base cloth for ink ribbons.
Inventor: HAMA KENJI
IPC: B41J31/04
Filed: 1993-09-03
Abstract: A base cloth, on which graphic spots do not occur, for a cassette type ink ribbon used for an impact printer. The cloth consists of a fabric composed of multifilament threads of synthetic fiber, and is characterized in that the fineness of a warp constituting this fabric is 30-50D with the number of twists thereof in the range of 330-600 T/M.
Patent EP-0675904-A4 (EP)
Title: Human neutralizing monoclonal antibodies to human immunodeficiency virus.
Inventor: BURTON DENNIS R
IPC: A61K49/00
Filed: 1993-09-30
Abstract: The present invention describes human monoclonal antibodies which immunoreact with and neutralize human immunodeficiency virus (HIV). Also disclosed are immunotherapeutic and diagnostic methods of using the monoclonal antibodies, as well as cell line for producing the monoclonal antibodies.
Patent EP-0697909-A4 (EP)
Inventor: LUTHI OSCAR
IPC: B30B9/20
Filed: 1994-05-05
Abstract: L'invention se rapporte à un tablier anti-remouillage pour cylindres exprimeurs (3), servant à accroître la concentration de pâte dans la suspension fibreuse afin de la faire passer d'approximativement 4 % à environ 30 à 50 %. On obtient cette caractéristique en inclinant l'orientation des trous de drainage (140) de l'enveloppe des cylindres vers le bord avant des compartiments de drainage situés à l'intérieur de ladite enveloppe. Pour éviter de devoir installer les cylindres selon une symétrie spéculaire précise, on prévoit un mécanisme ayant pour fonction de réduire au minimum le remouillage aux vitesses de production pratiques, à l'aide de plaques déviatrices (175, 177) qui orientent efficacement les flux de drainage dans la direction désirée. Ces plaque déviatrices peuvent être installées en permanence ou de façon amovible une fois qu'on a déterminé la symétrie spéculaire désirée des cylindres.
Patent EP-0748330-A4 (EP)
Title: L-nucleosides for the treatment of hepatitis b-virus and epstein-bar virus
Inventor: CHU CHUNG K
IPC: A61K31/7068
Filed: 1995-01-30
Abstract: A method for the treatment of a host, and in particular, a human, infected with HBV or EBV is provided that includes administering an HBV- or EBV- treatment amount of an L-nucleoside of formula (I) <CHEM> wherein R is a purine or pyrimidine base. In one preferred embodiment, the active compound is 2'-fluoro-5-methyl- beta -L-arabinofuranosyluridine (also referred to as L-FMAU) This compound is a potent antiviral agent against HBV and EBV and exhibits low cytotoxicity. Other specific examples of active compounds include N1-(2'-deoxy-2'-fluoro- beta -L-arabinofuranosyl)-5-ethyluracil, N1-(2'-deoxy-2'-fluoro- beta -L-arabinofuranosyl)-5-iodocytosine), and N1-(2'-deoxy-2'-fluoro- beta -L-arabinofuranosyl)-5-iodouracil. <IMAGE>
Patent EP-0776972-A4 (EP)
Title: GENE CODING FOR IgG-Fc-BINDING PROTEIN
Inventor: MORIKAWA MINORU
IPC: C12Q1/68
Filed: 1995-04-03
Abstract: A gene coding for an IgG-Fc-binding protein; a recombinant vector containing the gene; a host cell transformed by the vector; a process for producing a recombinant protein by culturing the host cell; and a recombinant protein having an IgG-Fc-binding activity produced by the above process.
Patent EP-0758254-A4 (EP)
Title: Magnetically-coupled implantable medical devices
Inventor: SOHN ZEV
IPC: A61M60/126
Filed: 1995-05-02
Abstract: Medical apparatus includes an external drive magnet mounted for rotation externally of a subject's body, an implantable driven magnet configured and dimensioned to be implantable in the subject's body and mounted for rotation by magnetic coupling with the drive magnet and an implantable device mechanically coupled to the driven magnet to be driven thereby. The driven magnet is mountable for rotation in the subject's body about an axis of rotation which is not collinear with the axis of rotation of the external drive magnet such that the magnetic poles of the external drive magnet are magnetically coupled sequentially with the magnetic poles of the implanted driven magnet to rotate the implanted driven magnet, thereby providing flexibility in the location, design and dimensions of the implanted driven magnet, and in the speed and torque ratios between the two magnets.
Patent EP-0768949-A4 (EP)
Inventor: TINGLEY DANIEL A
IPC: D04H5/08
Filed: 1995-10-27
Abstract: Pièce de charpente en bois, telle qu'une poutre en bois lamellé, une poutre en I en bois ou une ferme, qui comprend des panneaux de renforcement (22) en fibres synthétiques. Lesdits panneaux de renforcement (22) comportent des fibres synthétiques multiples (24) qui sont disposées parallèlement les unes aux autres et alignées dans la direction longitudinale du panneau et, partant, de la pièce de charpente en bois. Les fibres (24) sont maintenues en position par un encastrement (26) en résine. De préférence, la surface du panneau de renforcement (22) est traitée de telle manière que ledit panneau puisse adhérer à la pièce de charpente à l'aide de colles non époxy, telles que du résorcinol, utilisées couramment dans l'industrie des poutres lamellées.
Patent EP-0817643-A4 (EP)
Title: Compounds and compositions for delivering active agents
Inventor: LEONE-BAY ANDREA
IPC: A61K38/095
Filed: 1996-04-01
Abstract: The present invention relates to modified amino acids for delivering active agents selected from a group consisting of compounds the formulae of which are indicated in the description, further to pharmaceutical compositions containing active substances and compounds selected from the group consisting of compounds for delivering the active agents, as well as dosage unit forms containing such pharmaceutical composition process for the preparation of such pharmaceutical compositions.
Patent EP-0838010-A4 (EP)
Inventor: SPEARS JAMES R
IPC: C01B13/00
Filed: 1996-06-03
Abstract: Un procédé et un appareil (10) permettent d'introduire un gaz sous haute pression partielle dans un liquide. L'appareil possède un dispositif de transfert de gaz (12) comportant une enceinte (14) laquelle comprend une région amont (16) et une région avale (18) entre lesquelles se trouve une région (20) de contact entre le gaz et le liquide ayant des éléments de contact (22) tels que des fibres microporeuses creuses. Un réservoir de gaz (36) fournit le gaz à haute pression (P) à une cuve (38) contenant un liquide appauvri en gaz ainsi qu'au dispositif (12) de transfert de gaz. Le réservoir (36) de gaz a une pression hydrostatique afin de pousser le liquide au travers des éléments de contact (22) et de propulser le gaz autour des éléments de contact afin que le gaz ne se diffuse pas au travers des éléments de contact. Le liquide enrichi par le gaz est ensuite conduit vers un canal (44) d'écoulement à haute résistance pour amener l'écoulement vers un site d'interêt sans effervescence, sans formation de bulles ni disruption importante de l'écoulement laminaire.
Patent EP-0837948-A4 (EP)
Title: Device and method for detecting microorganisms
Inventor: READ KAREN A
IPC: C12M1/24
Filed: 1996-06-04
Abstract: A method and a sealable, sterilizable vessel for detecting the presence of microorganisms in a specimen, the vessel containing a liquid culture medium and a sensor with an indicator medium therein. A gas permeable membrane with a gas impermeable removable seal thereon are provided in a wall of the vessel. If the microorganism to be detected is an anaerobic organism, then the gas impermeable seal is left in place. If the microorganism to be detected is an aerobic organism, then the gas impermeable seal is removed so as to allow the passage of oxygen into the vessel. In a preferred embodiment, the gas permeable membrane allows the passage of oxygen into the vessel while at least partly restricting the passage of carbon dioxide to outside of the vessel. Changes in the indicator medium resulting from a change in gas production (CO2, NH2, H2S, etc.), volatile acid production or pH concentration in the medium, are detected from outside the vessel.
Patent EP-0855398-A4 (EP)
Title: Sesquiterpene derivatives having antiviral activity
Inventor: KAMIGAUCHI TOSHIYUKI
IPC: C07D491/10
Filed: 1996-09-25
Abstract: A compound of the formula (I): <CHEM> or a pharmaceutically acceptable salt, or a hydrate thereof, a process for preparing said compound, and a pharmaceutical composition having antiviral activity which comprise said compound.
Patent EP-0874629-A4 (EP)
Title: ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS
Inventor: QUAN MIMI LIFEN
IPC: C07D413/12
Filed: 1996-12-17
Abstract: Isoxazolines, isothiazolines and pyrazolines which are inhibitors of Factor Xa, pharmaceutical compositions containing these compounds, and methods of using these compounds as anticoagulant agents for treatment and prevention of thromboembolic disorders. The compounds can be represented by formula (I) where X is O, S or NR<15>.
Patent EP-0907918-A4 (EP)
Inventor: BAKER BERNARD R III
IPC: G06Q30/02
Filed: 1997-06-24
Abstract: Système et méthode informatiques permettant aux consommateurs de tirer meilleur profit de divers avantages qui sont offerts par plusieurs fournisseurs de biens et de services, lesdits avantages étant expressément réservés aux consommateurs faisant partie d'un ou de plusieurs organismes d'habilitation. Le système inclut une mémoire destinée à stocker des informations sur les consommateurs, sur l'organisme d'habilitation et sur la corrélation des avantages. On utilise un matériel informatique d'entrée pour introduire dans le système informatique certaines informations d'identification d'un consommateur et avec un ensemble de données relatives au plan d'achats dudit consommateur. Le système compare les informations d'identification avec celles qui concernent le consommateur pour déterminer les organismes d'habilitation auxquels est affilié, le cas échéant, ledit consommateur. L'information sur lesdits organismes est ensuite analysée, de pair avec l'information sur la corrélation des avantages, dans le but de déterminer si un des organismes auxquels est affilié le consommateur offre un avantage potentiellement applicable aux données sur le plan d'achats. De plus, le système détermine si les données sur le plan d'achats satisfont aux conditions d'obtention de l'avantage potentiellement applicable et affiche les résultats.
Patent EP-0914350-A4 (EP)
Title: Oxygen-curable coating composition
Inventor: CANTOR STEPHEN E
IPC: C09D4/00
Filed: 1997-07-18
Abstract: An acrylate composition, especially useful for producing conformal coatings on circuit board assemblies, includes a photo-initiator and an air-curing system, the latter being comprised of a compound having multiple allyloxy groups in its molecule and a transition metal salt catalyst. The composition is highly stable against auto-induced reaction in the absence of oxygen and at room temperature; it contains no active oxygen catalyst and no nonreactive diluent, and is advantageously formulated as a one-part product.
Patent EP-0979426-A4 (EP)
Inventor: HOBBS DOUGLAS S
IPC: G03F7/00
Filed: 1997-06-10
Abstract: L'invention concerne un système d'outil et un procédé lithographiques de formation de motifs à haute résolution, à haut rendement, de grand champ, destinés aux milieux de production. Ledit système comprend un générateur de diagrammes interférométriques (10) avec lequel trois ou quatre faisceaux optiques cohérents (27a, 27b, 27c) sont organisés selon un système souple d'expansion, de filtrage, d'ouverture et d'amenée de faisceaux. Un positionnement et une mise en forme optimisés des faisceaux d'éclairage permettent une bonne uniformité des motifs sur grande surface. Un système de stabilisation passif permet d'obtenir des diagrammes interférométriques entièrement modulés dans des milieux de production à fortes vibrations acoustiques et mécaniques.
Patent EP-0928203-A4 (EP)
Title: Gene therapy for inhibition of angiogenesis
Inventor: THOMAS KENNETH A JR
IPC: A61P17/06
Filed: 1997-09-24
Abstract: The present invention relates to methods of gene therapy for inhibiting angiogenesis associated with solid tumor growth, tumor metastasis, inflammation, psoriasis, rheumatoid arthritis, hemangiomas, diabetic retinopathy, angiofibromas, and macular degeneration Gene therapy methodology is disclosed for inhibition of primary tumor growth and metastasis by gene transfer of a nucleotide sequence encoding a soluble form of a VEGF tyrosine kinase receptor to a mammalian host. The transferred nucleotide sequence transcribes mRNA and a soluble receptor protein which binds to VEGF in extracellular regions adjacent to the primary tumor and vascular endothelial cells. Formation of a sVEGF-R/VEGF complex will prevent binding of VEGF to the KDR and FLT-1 tyrosine kinase receptors, antagonizing transduction of the normal intracellular signals associated with vascular endothelial cell-induced tumor angiogenesis. In addition, expression of a soluble receptor tyrosine kinase may also impart a therapeutic effect by binding either with or without VEGFs to form non-functional heterodimers with full-length VEGF-specific tyrosine kinase receptors and thereby inhibiting the mitogenic and angiogenic activities of VEGFs.
Patent EP-0961636-A4 (EP)
Inventor: MULLER DAVID F
IPC: A61B18/00
Filed: 1998-01-13
Abstract: L'invention porte sur un appareil de traitement par rayonnement d'états dermatologiques, cet appareil comprenant un dispositif de Peltier (20) destiné à refroidir la zone de la peau du patient à traiter. Le dispositif de refroidissement de Peltier présente une surface froide en communication thermique avec la zone de la peau à traiter, et une surface chaude comportant un orifice (30) s'étendant entre les surfaces froide et chaude par lesquelles le rayonnement est dirigé sur la zone de la peau à traiter. Selon une réalisation, une lentille (80) disposée dans l'orifice (30) du dispositif de refroidissement répartit l'effet de refroidissement de façon à refroidir toute la zone de traitement relativement uniformément. Une sonde thermique (70) capte la température de la zone de traitement et est utilisée pour réguler le dispositif de Peltier et/ou la source de rayonnement de sorte que la zone de traitement ne dépasse pas une température prédéterminée. Différentes sources de rayonnement sont appropriées pour être utilisées avec le dispositif de Peltier telles que des lasers et des lampes à décharge gazeuse, à savoir des lampes à arc et des lampes éclair.
Patent EP-1029541-A4 (EP)
Title: Therapeutic or prophylactic agent for glomerulopathy
Inventor: KURIHARA HIDETAKE
IPC: C07D209/04
Filed: 1998-07-17
Abstract: Agent for treatment or prevention of glomerulopathy comprise a sulphonamide derivative of formula R4-R3-SO2-N(R2)C(R1)COY (I) or its salt or hydrate. R1, R2 = H or optionally substituted lower alkyl, aryl, aralkyl, heteroaryl or heteroarylalkyl; R3 = 4-phenylene or 2,5-thiophendiyl; R4 = OPh, Tet-Ph, Ctriple boundCPh, NHCOPh, Het-Ph, phenyl parasubstituted by R6 or 2-R5-thiophen-5-ylethynyl; Ph = phenyl para-substituted by R6; Tet = tetrazol-2,5-diyl; Het = oxazol-2,5-diyl or oxadiazol-3,5-diyl bonded to phenyl through the 5 and 3 positions respectively or thiophen-2,5-diyl; R5 = H, OH, lower alkylthio, SH, cycloalkyl, halo, COOH, lower alkoxycarbonyl, NO2, CN, lower haloalkyl, aryloxy, guanidino, lower alkenyl, lower alkynyl, acyl, acyloxy, CONRaRb, NRcCORd or optionally substituted lower alkoxy, amino, lower alkyl, unsaturated heterocyclyl or heteroaryl; Ra-Rc = H, lower alkyl or aralkyl; Rd = lower alkyl, aryl or aralkyl; R6 = cycloalkyl, lower alkoxy, halo, lower alkylthio, carboxy, lower alkoxycarbonyl, aryloxy, phenyl or optionally substituted lower alkyl, amino, unsaturated heterocyclyl or heteroaryl; Y = NHOH or OH. (I) are new when R4 = 2-R5-thiophen-5-ylethynyl, Ph-Tet or Ph-Het1 and R3 = 2,5-thiophen-diyl; or R4 = Ph-Het2 and R3 = 4-phenylene; Het1 = oxazol-2,5-diyl; Het2 = 2,5-thiophendiyl, tetrazol-2,5-diyl bonded to Ph through the 5 position or oxadiazol-3,5-yl; R5, R6 = H, lower alkylthio, halo or optionally substituted alkoxy, amino, alkyl or unsaturated heterocyclyl and R2 = H or lower alkyl.